Clinical Trials Browser

Leukemia, Promyelocytic, Acute × Bortezomib × Clear all

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

NCT01950611 2013-09-25

PIAPL

Phase 2 Unknown

30 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00005064 2013-01-23

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

Phase 1 Completed

30 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

PIAPL

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome